163 related articles for article (PubMed ID: 17895316)
61. Typical hormonal profiles are accompanied by increased immunoreactivity of theca folliculi steroid 17 alpha-hydroxylase P450 in polycystic ovary syndrome.
Katulski K; Bornstein S; Figiel M; Wand D; Warenik-Szymankiewicz A; Trzeciak WH
J Endocrinol Invest; 1998 May; 21(5):304-9. PubMed ID: 9648052
[TBL] [Abstract][Full Text] [Related]
62. Transforming growth factor-beta inhibits ovarian 17 alpha-hydroxylase activity by a direct noncompetitive mechanism.
Fournet N; Weitsman SR; Zachow RJ; Magoffin DA
Endocrinology; 1996 Jan; 137(1):166-74. PubMed ID: 8536609
[TBL] [Abstract][Full Text] [Related]
63. The mediator complex subunit 1 enhances transcription of genes needed for adrenal androgen production.
Nakamura Y; Xing Y; Sasano H; Rainey WE
Endocrinology; 2009 Sep; 150(9):4145-53. PubMed ID: 19497978
[TBL] [Abstract][Full Text] [Related]
64. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries.
Gilling-Smith C; Willis DS; Beard RW; Franks S
J Clin Endocrinol Metab; 1994 Oct; 79(4):1158-65. PubMed ID: 7962289
[TBL] [Abstract][Full Text] [Related]
65. Hormonal regulation of steroidogenic enzyme gene expression in Leydig cells.
Payne AH; Youngblood GL; Sha L; Burgos-Trinidad M; Hammond SH
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):895-906. PubMed ID: 22217834
[TBL] [Abstract][Full Text] [Related]
66. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation.
Mesiano S; Katz SL; Lee JY; Jaffe RB
J Clin Endocrinol Metab; 1997 May; 82(5):1390-6. PubMed ID: 9141522
[TBL] [Abstract][Full Text] [Related]
67. Inhibition of CYP17 expression by adrenal androgens and transforming growth factor beta in adrenocortical cells.
Biernacka-Łukanty JM; Lehmann TP; Trzeciak WH
Acta Biochim Pol; 2004; 51(4):907-17. PubMed ID: 15625562
[TBL] [Abstract][Full Text] [Related]
68. Hypersecretion of androgens by polycystic ovaries: the role of genetic factors in the regulation of cytochrome P450c17 alpha.
Franks S; White D; Gilling-Smith C; Carey A; Waterworth D; Williamson R
Baillieres Clin Endocrinol Metab; 1996 Apr; 10(2):193-203. PubMed ID: 8773744
[TBL] [Abstract][Full Text] [Related]
69. Expression of genes encoding corticotropin-releasing factor (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary.
Asakura H; Zwain IH; Yen SS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2720-5. PubMed ID: 9253360
[TBL] [Abstract][Full Text] [Related]
70. Transforming growth factor-beta promotes differentiation of ovarian thecal-interstitial cells but inhibits androgen production.
Magoffin DA; Gancedo B; Erickson GF
Endocrinology; 1989 Oct; 125(4):1951-8. PubMed ID: 2791974
[TBL] [Abstract][Full Text] [Related]
71. Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells.
Ho CK; Wood JR; Stewart DR; Ewens K; Ankener W; Wickenheisser J; Nelson-Degrave V; Zhang Z; Legro RS; Dunaif A; McAllister JM; Spielman R; Strauss JF
J Clin Endocrinol Metab; 2005 Dec; 90(12):6596-602. PubMed ID: 16159937
[TBL] [Abstract][Full Text] [Related]
72. Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling?
Glister C; Richards SL; Knight PG
Endocrinology; 2005 Apr; 146(4):1883-92. PubMed ID: 15625241
[TBL] [Abstract][Full Text] [Related]
73. Aberrant H19 Expression Disrupts Ovarian Cyp17 and Testosterone Production and Is Associated with Polycystic Ovary Syndrome in Women.
Chen Z; Liu L; Xi X; Burn M; Karakaya C; Kallen AN
Reprod Sci; 2022 Apr; 29(4):1357-1367. PubMed ID: 34655046
[TBL] [Abstract][Full Text] [Related]
74. Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5'-UTR in patients with polycystic ovarian syndrome.
Marszalek B; Laciński M; Babych N; Capla E; Biernacka-Lukanty J; Warenik-Szymankiewicz A; Trzeciak WH
Gynecol Endocrinol; 2001 Apr; 15(2):123-8. PubMed ID: 11379008
[TBL] [Abstract][Full Text] [Related]
75. Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain.
Hirsch A; Hahn D; Kempná P; Hofer G; Nuoffer JM; Mullis PE; Flück CE
Endocrinology; 2012 Sep; 153(9):4354-66. PubMed ID: 22778212
[TBL] [Abstract][Full Text] [Related]
76. Human ovarian theca cells in culture.
Wickenheisser JK; Nelson-DeGrave VL; McAllister JM
Trends Endocrinol Metab; 2006 Mar; 17(2):65-71. PubMed ID: 16460956
[TBL] [Abstract][Full Text] [Related]
77. Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome.
Wickenheisser JK; Biegler JM; Nelson-Degrave VL; Legro RS; Strauss JF; McAllister JM
PLoS One; 2012; 7(11):e48963. PubMed ID: 23155436
[TBL] [Abstract][Full Text] [Related]
78. miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.
McAllister JM; Han AX; Modi BP; Teves ME; Mavodza GR; Anderson ZL; Shen T; Christenson LK; Archer KJ; Strauss JF
Endocrinology; 2019 Aug; 160(8):1964-1981. PubMed ID: 31184707
[TBL] [Abstract][Full Text] [Related]
79. Cytochrome P450 17 (CYP17) is involved in endometrial cancinogenesis through apoptosis and invasion pathways.
Chen Y; Saini S; Zaman MS; Hirata H; Shahryari V; Deng G; Dahiya R
Mol Carcinog; 2011 Jan; 50(1):16-23. PubMed ID: 20886547
[TBL] [Abstract][Full Text] [Related]
80. Xenopus laevis CYP17 regulates androgen biosynthesis independent of the cofactor cytochrome b5.
Yang WH; Hammes SR
J Biol Chem; 2005 Mar; 280(11):10196-201. PubMed ID: 15640159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
